Stellar Biotechnologies Appoints Tessie Che, Ph.D. to Board of Directors
25. September 2013 09:05 ET
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Sep 25, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), is very pleased to announce the appointment of Tessie...
Stellar Biotechnologies Closes US$12 Million Private Placement Financing
23. September 2013 09:05 ET
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Sep 23, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today, further to its news releases of...
Stellar Biotechnologies Raises US$10 Million in Initial Closing of Private Placement
10. September 2013 14:59 ET
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Sep 10, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today that, further to its news release of...
Stellar Biotechnologies to Present at Rodman and Renshaw 13th Annual Global Investment Conference From September 8-10, 2013
29. August 2013 09:05 ET
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Aug 29, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today that it will present at the Rodman and...
Stellar Biotechnologies, Inc. Announces US $12,000,000 Private Placement
22. August 2013 09:05 ET
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Aug 22, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) announces its intent to close a private placement of up...
Stellar Biotechnologies Issues President's Letter to Shareholders
06. August 2013 09:05 ET
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Aug 6, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), is pleased to announce that it has issued a letter from...
Stellar Biotechnologies Acquires Exclusive, Worldwide License to Clostridium Difficile Immunotherapy Technology
30. Juli 2013 09:05 ET
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Jul 30, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today that the Company has acquired the...
Stellar Biotechnologies Announces Joint Research on Clostridium Difficile Immunotherapy Accepted for Presentation
24. Juli 2013 18:01 ET
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - Jul 24, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), announced today that a preclinical abstract on...
Stellar Biotechnologies Presents at Annual 2013 National Science Foundation Conference
28. Mai 2013 09:00 ET
|
Stellar Biotechnologies
PORT HUENEME, CA--(Marketwired - May 28, 2013) - Stellar Biotechnologies, Inc. ("Stellar" or the "Company") (OTCQB: SBOTF) (TSX VENTURE: KLH) today announced the presentation of a poster at...
Stellar Biotechnologies to Present at the Second Annual Marcum LLP Microcap Conference
21. Mai 2013 09:33 ET
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwired - May 21, 2013) - Stellar Biotechnologies, Inc. (OTCQB: SBOTF) (TSX VENTURE: KLH) announced today that Frank Oaks, President & CEO and Darrell Brookstein,...